Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd (SYNCOMF) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 66,50,811
May 30, 2025 14:44 IST Open
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹22.22
₹0.58 (2.68%)
21.41Low
Today’s Performance
22.63High
10.95Low
52 Week’s Performance
27.90High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day2.82%
  • 1 Week9.79%
  • 1 Month28.73%
  • 3 Months41.07%
  • 6 Months7.61%
  • 1 Year74.52%
  • 3 Years38.76%
  • 5 Years-%

bt_logoPeer Comparison

Syncom Formulations (India) Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Price

₹22.22

Syncom Formulations (India) Ltd

₹1,686.00

Sun Pharmaceutical Industries Ltd

₹6,563.50

Divis Laboratories Ltd

₹1,482.90

Cipla Ltd

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta1.18
  • 52-Week Low (₹)10.95
  • 52-Week High (₹)27.90
  • Price-to-Book (X)*5.95
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*40.87
  • Earnings Per Share (₹)0.53
  • Market Cap (₹ Cr.)*2,034.16
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Hailey Bieber Becomes A Beauty Billionaire | Rhode Acquired For $1 Billion By e.l.f.2:35Hailey Bieber Becomes A Beauty Billionaire | Rhode Acquired For $1 Billion By e.l.f.
Pakistan's Terror Playbook: JeM Reboots After Operation Sindoor2:10Pakistan's Terror Playbook: JeM Reboots After Operation Sindoor
Sunil Bharti Mittal: Industry Still Hasn’t Earned Complete Trust Of Stakeholders1:43Sunil Bharti Mittal: Industry Still Hasn’t Earned Complete Trust Of Stakeholders
Modi’s Operation Sindoor Strikes Hard As Pakistan Begs For Peace, But Hosts Terror Rallies At Home2:28Modi’s Operation Sindoor Strikes Hard As Pakistan Begs For Peace, But Hosts Terror Rallies At Home
Trump-Musk Bromance Ends: $160Bn Saver Elon Musk Leaves White House Role Over Budget Rift1:51Trump-Musk Bromance Ends: $160Bn Saver Elon Musk Leaves White House Role Over Budget Rift
Trump’s Crypto Empire Rises In Pakistan | Secret Deals, Gold Mines & Military Ties4:27Trump’s Crypto Empire Rises In Pakistan | Secret Deals, Gold Mines & Military Ties
Cummins India Up 7%, MD Reveals Future Plans And Financial Outlook19:11Cummins India Up 7%, MD Reveals Future Plans And Financial Outlook
Sunil Mittal: CII Has To Back ‘One Nation, One Election’, Too Many Economic Disruptions During Polls2:07Sunil Mittal: CII Has To Back ‘One Nation, One Election’, Too Many Economic Disruptions During Polls
TACO – A Wall Street Acronym For Trump Which Made The US President Furious2:28TACO – A Wall Street Acronym For Trump Which Made The US President Furious
Indigenisation To Integration: Navy’s Big Bet On Indian Industry For Next-Gen Naval Warfare6:45Indigenisation To Integration: Navy’s Big Bet On Indian Industry For Next-Gen Naval Warfare
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

bt_logoRatio Analysis

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)
Promoters (50.57%)
Domestic institutional investors (0.00%)
Foreign Institutional Investors (1.86%)
Public & Others (46.55%)
Government Holding (0.00%)
Corporate Holding (1.02%)

bt_logoDeals

25 Sep, 2017SELL
SAMIR NARENDRA GUPTA
Qty2000000
Average Price₹1.46
25 Sep, 2017BUY
NARENDRAKUMAR BHAGWANDAS GUPTA
Qty2000000
Average Price₹1.46
30 Jan, 2015BUY
ALACRITY SECURITIES LIMITED
Qty500000
Average Price₹5.8
30 Jan, 2015SELL
ODYSSEY CORPORATION LIMITED
Qty500000
Average Price₹5.8
03 Feb, 2014BUY
SUNITA MOTILAL SINHA
Qty543750
Average Price₹5.5
03 Feb, 2014SELL
KIRIT VASUDEO DAVE
Qty543750
Average Price₹5.5
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Syncom Formulations (India) Ltd share price previously?
Syncom Formulations (India) Ltd share price was up by 2.68% from the previous closing price of ₹21.64.
Who are peers of Syncom Formulations (India) Ltd?
The peers of Syncom Formulations (India) Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd.
Who is/are the promoter/promoters of Syncom Formulations (India) Ltd?
The promotor/promotors of Syncom Formulations (India) Ltd are Kedarmal Bankda, Vijay Shankarlal Bankda, Rinki Bankda, Ruchi Jindal, Vaishali Agrawal, Ritesh Kumar Lunkad, Ankit Jain.
What has been 52-week high of Syncom Formulations (India) Ltd stocks?
The highest price of Syncom Formulations (India) Ltd stock is ₹27.90 in the last 52-week.
What is the share price of Syncom Formulations (India) Ltd (SYNCOMF) today on NSE?
As on May 30, 2025 Syncom Formulations (India) Ltd (SYNCOMF)’s share price on NSE is Rs 22.22
What is the market cap of Syncom Formulations (India) Ltd (SYNCOMF)?
The current market capitalisation of Syncom Formulations (India) Ltd (SYNCOMF) is 2,034.16 crores
What is Syncom Formulations (India) Ltd Share symbol?
The symbol of Syncom Formulations (India) Ltd is SYNCOMF.
What is the PE ratio of Syncom Formulations (India) Ltd (SYNCOMF)?
The current PE ratio of Syncom Formulations (India) Ltd (SYNCOMF) is 40.87.
What is the PB ratio of Syncom Formulations (India) Ltd (SYNCOMF)?
The current PB ratio of Syncom Formulations (India) Ltd (SYNCOMF) is 5.95.
Today’s High & Low share prices of Syncom Formulations (India) Ltd (SYNCOMF) on NSE?
Today, the share price of Syncom Formulations (India) Ltd (SYNCOMF) on NSE touched a high of Rs 22.63 and a low of Rs 21.41
What price did Syncom Formulations (India) Ltd (SYNCOMF) shares open on the NSE today?
On NSE, the share price of Syncom Formulations (India) Ltd (SYNCOMF) opened at Rs 21.64
What is the 52-week high of Syncom Formulations (India) Ltd (SYNCOMF)?
The 52-week high price of Syncom Formulations (India) Ltd (SYNCOMF) is Rs 27.90
What is the 52-week low of Syncom Formulations (India) Ltd (SYNCOMF)?
The 52-week low price of Syncom Formulations (India) Ltd (SYNCOMF) is Rs 10.95

bt_logoAbout Syncom Formul.

Syncom Formulations (India) Ltd, incorporated in the year 1988, has its registered office in 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093, 91-22-30887744, 91-22-30887755. The main industry in which Syncom Formulations (India) Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Syncom Formulations (India) Ltd is/are Sanjay Mehta & Associates. In the main management, Kedarmal Bankda is chairman and Vaishali Agrawal is the company secretary for Syncom Formulations (India) Ltd.

  • KB
    Kedarmal BankdaChairman & Wholetime Director
  • VSB
    Vijay Shankarlal BankdaManaging Director
  • RB
    Rinki BankdaWhole-time Director
  • RJ
    Ruchi JindalIndependent Director
  • VA
    Vaishali AgrawalCompany Sec. & Compli. Officer
  • RKL
    Ritesh Kumar LunkadIndependent Director
  • AJ
    Ankit JainIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.